SWEDISH ORPHAN BIOVITRUM A/S: Financial statements 2013
CVR: 19179079
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
SWEDISH ORPHAN BIOVITRUM A/S (CVR 19179079) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 16,000,801 and a net result of DKK 664,628 compared with DKK 580,420 the year before. That is an increase of 3.2% compared with the year before. Equity in the 2013 report amounted to DKK 1,164,628. The solvency ratio was 16.3%.
- Gross Profit
- DKK 16,000,801
- Profit/Loss
- DKK 664,628
- Equity
- DKK 1,164,628
- Total Assets
- DKK 7,145,051
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 16M | 665K | 1.2M | - |
| 2012 | 22.1M | 15.5M | 580K | 1.1M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
SWEDISH ORPHAN BIOVITRUM A/S has published its annual report for 2012. Revenue came to DKK 22,088,115, and the net result was DKK 580,420.
About SWEDISH ORPHAN BIOVITRUM A/S
SWEDISH ORPHAN BIOVITRUM A/S is a Danish company of the type Aktieselskab based in Kgs.Lyngby, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named SWEDISH ORPHAN A/S and ORPHAN DENMARK A/S. The management consists of Bjørn Gustaf Östen Berglund. The board consists of Bjørn Gustaf Östen Berglund, Karl Henrik Stenqvist and Soufiane Fahmy. The company is owned by Swedish Orphan Biovitrum International AB. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 18,017,697 and a net result of DKK 3,269,269 compared with DKK 4,570,202 the year before. Equity in the 2025 report amounted to DKK 39,495,805.
